These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38847786)

  • 1. Marrow mesenchymal stem cell mediates diabetic nephropathy progression via modulation of Smad2/3/WTAP/m6A/ENO1 axis.
    Bai Y; Huang L; Fan Y; Li Y
    FASEB J; 2024 Jun; 38(11):e23729. PubMed ID: 38847786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imperatorin ameliorates kidney injury in diabetic mice by regulating the TGF-β/Smad2/3 signaling axis, epithelial-to-mesenchymal transition, and renal inflammation.
    Kundu S; Ghosh A; Yadav KS; Mugale MN; Sahu BD
    Eur J Pharmacol; 2024 Jan; 963():176250. PubMed ID: 38092315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines.
    Bai Y; Wang J; He Z; Yang M; Li L; Jiang H
    Med Sci Monit; 2019 Apr; 25():3069-3076. PubMed ID: 31023998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
    Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
    Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT.
    Lin S; Yu L; Ni Y; He L; Weng X; Lu X; Zhang C
    Diabetes Metab J; 2020 Feb; 44(1):158-172. PubMed ID: 31701691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminution of microRNA-98 alleviates renal fibrosis in diabetic nephropathy by elevating Nedd4L and inactivating TGF-β/Smad2/3 pathway.
    Zeng Y; Feng Z; Liao Y; Yang M; Bai Y; He Z
    Cell Cycle; 2020 Dec; 19(24):3406-3418. PubMed ID: 33315506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoN.
    Wang Y; Zhang X; Mao Y; Liang L; Liu L; Peng W; Liu H; Xiao Y; Zhang Y; Zhang F; Shi M; Liu L; Guo B
    Exp Mol Pathol; 2020 Apr; 113():104375. PubMed ID: 31917288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epiberberine ameliorated diabetic nephropathy by inactivating the angiotensinogen (Agt) to repress TGFβ/Smad2 pathway.
    Xiao Y; Deng J; Li C; Gong X; Gui Z; Huang J; Zhang Y; Liu Y; Ye X; Li X
    Phytomedicine; 2021 Mar; 83():153488. PubMed ID: 33571918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorate Nephrocyte Injury and Proteinuria in a Diabetic Nephropathy Rat Model.
    Chen L; Xiang E; Li C; Han B; Zhang Q; Rao W; Xiao C; Wu D
    J Diabetes Res; 2020; 2020():8035853. PubMed ID: 32405507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of centella asiatica granule on the expression of TGF-β
    Ma JW; Wang HT; Liu HF; Ding Y; Bai JQ; Zhang Z
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):69-73. PubMed ID: 29926663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis.
    Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D
    Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
    Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
    Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
    Wang Y; Lin C; Ren Q; Liu Y; Yang X
    Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse Umbilical Cord Mesenchymal Stem Cell Paracrine Alleviates Renal Fibrosis in Diabetic Nephropathy by Reducing Myofibroblast Transdifferentiation and Cell Proliferation and Upregulating MMPs in Mesangial Cells.
    Li H; Rong P; Ma X; Nie W; Chen Y; Zhang J; Dong Q; Yang M; Wang W
    J Diabetes Res; 2020; 2020():3847171. PubMed ID: 32455132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells.
    Wang YN; Zhao SL; Su YY; Feng JX; Wang S; Liao XM; Wang LN; Li JC; Meng P; Li HY; Zhang YF
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cell-derived exosomes improve diabetes mellitus-induced myocardial injury and fibrosis via inhibition of TGF-β1/Smad2 signaling pathway.
    Lin Y; Zhang F; Lian XF; Peng WQ; Yin CY
    Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):123-126. PubMed ID: 31880529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes.
    Nagaishi K; Mizue Y; Chikenji T; Otani M; Nakano M; Konari N; Fujimiya M
    Sci Rep; 2016 Oct; 6():34842. PubMed ID: 27721418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of IGFBP7 in Diabetic Nephropathy: TGF-β1 Induces IGFBP7 via Smad2/4 in Human Renal Proximal Tubular Epithelial Cells.
    Watanabe J; Takiyama Y; Honjyo J; Makino Y; Fujita Y; Tateno M; Haneda M
    PLoS One; 2016; 11(3):e0150897. PubMed ID: 26974954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Bone Marrow Mesenchymal Stem Cells on Plasminogen Activator Inhibitor-1 and Renal Fibrosis in Rats with Diabetic Nephropathy.
    Lang H; Dai C
    Arch Med Res; 2016 Feb; 47(2):71-7. PubMed ID: 27018336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-92d-3p suppresses the progression of diabetic nephropathy renal fibrosis by inhibiting the C3/HMGB1/TGF-β1 pathway.
    Zhang Y
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 33729484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.